Literature DB >> 22809257

Association of low plasma adiponectin with early diastolic dysfunction.

Smita I Negi1, Euy-Myoung Jeong, Irfan Shukrullah, Mihai Raicu, Samuel C Dudley.   

Abstract

Diastolic dysfunction (DD) with preserved left ventricular (LV) ejection fraction (EF) has been linked to obesity. Adiponectin is a cytokine related to obesity and obesity-linked cardiovascular complications. The authors aimed to determine the independent association of DD with adiponectin. Fifty patients with impaired relaxation DD and a normal EF and age-matched normal controls were recruited. Plasma levels of total and high molecular weight (HMW) adiponectin were measured. Mid and low molecular weight (MMW+LMW) fractions of adiponectin were calculated by subtracting HMW fraction from total adiponectin. The DD group had significantly lower total (median, 4.4 vs 12.7 μg/mL; P=.001), HMW fraction (median, 1.3 vs 3.4 μg/mL; P=.02), and MMW+LMW fraction of adiponectin (median, 3.8 vs 7.2 μg/mL; P=.01). Body mass index (BMI) negatively correlated with total (r:-0.46, P=.003), HMW (r:-0.32, P=.038), and MMW+LMW (r:-0.40, P=.006) fractions of adiponectin. DD had an independent association with both BMI (P<.05) and total adiponectin (P<.001) in linear regression model using sex, BMI, blood pressure, and total adiponectin as covariates. DD was associated with BMI (P=.02), HMW fraction (P=.03), and MMW+LMW fraction (P=.004) in similar linear regression analyses. Adiponectin deficiency may be one explanation for the adiposity-related cardiac oxidation known to be involved in the pathogenesis of DD.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22809257      PMCID: PMC3646250          DOI: 10.1111/j.1751-7133.2011.00276.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  36 in total

1.  Relation between epicardial adipose tissue and left ventricular mass.

Authors:  Gianluca Iacobellis; Maria Cristina Ribaudo; Alessandra Zappaterreno; Concetta Valeria Iannucci; Frida Leonetti
Journal:  Am J Cardiol       Date:  2004-10-15       Impact factor: 2.778

2.  Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Authors:  Caroline Kistorp; Jens Faber; Søren Galatius; Finn Gustafsson; Jan Frystyk; Allan Flyvbjerg; Per Hildebrandt
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

3.  The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study.

Authors:  J E Liu; V Palmieri; M J Roman; J N Bella; R Fabsitz; B V Howard; T K Welty; E T Lee; R B Devereux
Journal:  J Am Coll Cardiol       Date:  2001-06-01       Impact factor: 24.094

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 5.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

6.  Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction.

Authors:  Gad A Silberman; Tai-Hwang M Fan; Hong Liu; Zhe Jiao; Hong D Xiao; Joshua D Lovelock; Beth M Boulden; Julian Widder; Scott Fredd; Kenneth E Bernstein; Beata M Wolska; Sergey Dikalov; David G Harrison; Samuel C Dudley
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

7.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.

Authors:  Toshimitsu Yatagai; Shoichiro Nagasaka; Ataru Taniguchi; Mitsuo Fukushima; Tomoatsu Nakamura; Akira Kuroe; Yoshikatsu Nakai; Shun Ishibashi
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

8.  Role of left ventricular stiffness in heart failure with normal ejection fraction.

Authors:  Dirk Westermann; Mario Kasner; Paul Steendijk; Frank Spillmann; Alexander Riad; Kerstin Weitmann; Wolfgang Hoffmann; Wolfgang Poller; Matthias Pauschinger; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

9.  Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway.

Authors:  G Deng; Y Long; Y-R Yu; M-R Li
Journal:  Int J Obes (Lond)       Date:  2009-10-13       Impact factor: 5.095

10.  Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.

Authors:  C P Appleton; L K Hatle; R L Popp
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

View more
  10 in total

1.  Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction.

Authors:  Komei Tanaka; Richard M Wilson; Eric E Essick; Jennifer L Duffen; Philipp E Scherer; Noriyuki Ouchi; Flora Sam
Journal:  Circ Heart Fail       Date:  2014-08-22       Impact factor: 8.790

2.  Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms.

Authors:  Ping Li; Li Yang; Cui-Li Ma; Bo Liu; Xin Zhang; Rui Ding; Li-qi Bi
Journal:  Clin Rheumatol       Date:  2015-03-10       Impact factor: 2.980

3.  Weight History and Subclinical Myocardial Damage.

Authors:  Chiadi E Ndumele; Laura Cobb; Mariana Lazo; Natalie A Bello; Amil Shah; Vijay Nambi; Roger S Blumenthal; Gary Gerstenblith; Scott D Solomon; Christie M Ballantyne; Elizabeth Selvin; Josef Coresh
Journal:  Clin Chem       Date:  2017-11-20       Impact factor: 8.327

Review 4.  Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure.

Authors:  Tahnee Sente; An M Van Berendoncks; Vicky Y Hoymans; Christiaan J Vrints
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

5.  The Significance of the Effect of Visceral Adiposity on Left Ventricular Diastolic Function in the General Population.

Authors:  Naoko Sawada; Masao Daimon; Takayuki Kawata; Tomoko Nakao; Koichi Kimura; Koki Nakanishi; Makoto Kurano; Megumi Hirokawa; Boqing Xu; Yuko Yamanaka; Tomoko S Kato; Masafumi Watanabe; Yutaka Yatomi; Issei Komuro
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 6.  Crossroads between Estrogen Loss, Obesity, and Heart Failure with Preserved Ejection Fraction.

Authors:  Allan Kardec Nogueira de Alencar; Hao Wang; Gláucia Maria Moraes de Oliveira; Xuming Sun; Gisele Zapata-Sudo; Leanne Groban
Journal:  Arq Bras Cardiol       Date:  2021-12       Impact factor: 2.000

7.  Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.

Authors:  Li Ping Liao; Yang Yang; Yilin Wu; Weizhen Li
Journal:  Clin Cardiol       Date:  2022-06-29       Impact factor: 3.287

8.  Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography.

Authors:  Antoine Kossaify; Nayla Nicolas
Journal:  Clin Med Insights Cardiol       Date:  2013-02-21

9.  Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus.

Authors:  Ryoko Ichikawa; Masao Daimon; Tetsuro Miyazaki; Takayuki Kawata; Sakiko Miyazaki; Masaki Maruyama; Shuo-Ju Chiang; Hiromasa Suzuki; Chiharu Ito; Fumihiko Sato; Hirotaka Watada; Hiroyuki Daida
Journal:  Cardiovasc Diabetol       Date:  2013-02-27       Impact factor: 9.951

10.  Obesity and Subtypes of Incident Cardiovascular Disease.

Authors:  Chiadi E Ndumele; Kunihiro Matsushita; Mariana Lazo; Natalie Bello; Roger S Blumenthal; Gary Gerstenblith; Vijay Nambi; Christie M Ballantyne; Scott D Solomon; Elizabeth Selvin; Aaron R Folsom; Josef Coresh
Journal:  J Am Heart Assoc       Date:  2016-07-28       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.